Introducing an effective new tuberculosis vaccine in low- and middle-income countries could lead to billions of dollars in potential health and economic benefits, according to a modeling study led by Harvard Chan School.
The Global Health Delivery Intensive program at Harvard T.H. Chan School of Public Health brings together mid-career professionals from around the world to gain skills and think through issues relating to improving health care delivery for patients.
Researchers have discovered a new form of altered drug susceptibility—dubbed antibiotic resilience—that enables Mycobacterium tuberculosis to survive antibiotic treatment.
Scaling up prenatal micronutrient supplementation could have population-wide benefits for the next generation.
Harvard Chan School faculty members Wafaie Fawzi, Vikram Patel, and John Quackenbush were elected to the National Academy of Medicine.
Karl Lauterbach, Germany’s federal minister of health, discussed the G7 Pact for Pandemic Readiness at a Harvard Chan School seminar.
Public health leaders from around the world gathered at Harvard University for a week-long course to learn the latest developments from experts and discuss new strategies for eradicating malaria.
A hematology fellow from Australia, Eddie Cliff, MPH ’22, cares just as deeply about the well-being of his patients as he does about improving health systems as a whole. He’s also a writer published in the New York…
Experts urge governments and communities to establish systems that support health and productivity for aging populations.
Patience Saaka is a physician from Ghana with a passion for promoting equity in health care and ending gender-based violence.